InflaRx N.V. (IFRX) stock
IFRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.15−0.03 (-2.54%)
Close on Nov 17, 2026Market cap $83.14MP/E –Yield –
InflaRx operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
For fiscal 2025 it was -€35.31M. The highest annual figure on record is -€3.31M in fiscal 2015.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -€35.31M | – |
| FY2024 | Dec 31, 2024 | -€48.56M | – |
| FY2023 | Dec 31, 2023 | -€37.81M | – |
| FY2022 | Dec 31, 2022 | -€33.74M | – |
| FY2021 | Dec 31, 2021 | -€39.94M | – |
| FY2020 | Dec 31, 2020 | -€36.53M | – |
| FY2019 | Dec 31, 2019 | -€43.20M | – |
| FY2018 | Dec 31, 2018 | -€21.55M | – |
| FY2017 | Dec 31, 2017 | -€12.15M | – |
| FY2016 | Dec 31, 2016 | -€4.99M | – |
| FY2015 | Dec 31, 2015 | -€3.31M | – |
See a number that looks wrong?